A cervical abnormality risk prediction model: can we use clinical information to predict which patients with ASCUS/LSIL Pap tests will develop CIN 2/3 or AIS?
about
Study of 2 years follow-up of referral patients with abnormal Pap smearIdentification of potential missed opportunities for human papillomavirus (HPV) vaccination in women referred to an academic colposcopy clinic for evaluation of abnormal cervical cytology.Frequency of precancerous changes and cervical cancer recorded in three health centres in tuzla canton in period 2010-2011.HPV infection and p16 promoter methylation as predictors of ASC-US/LSIL progression.HPV prevalence and HPV-related dysplasia in elderly women.
P2860
A cervical abnormality risk prediction model: can we use clinical information to predict which patients with ASCUS/LSIL Pap tests will develop CIN 2/3 or AIS?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A cervical abnormality risk pr ...... s will develop CIN 2/3 or AIS?
@en
type
label
A cervical abnormality risk pr ...... s will develop CIN 2/3 or AIS?
@en
prefLabel
A cervical abnormality risk pr ...... s will develop CIN 2/3 or AIS?
@en
P2093
P2860
P1476
A cervical abnormality risk pr ...... s will develop CIN 2/3 or AIS?
@en
P2093
Brittany M Charlton
Jenny L Carwile
Karin B Michels
Sarah Feldman
P2860
P304
P356
10.1097/LGT.0B013E3182730FEC
P577
2013-07-01T00:00:00Z